Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04287075 · ClinicalTrials.gov registry record
Surgical Treatment of Chronic Neuropathic Pain
A clinical trial, sponsored by Axogen Corporation.
- Terminated
- Registry status
- 8
- Enrollment target
NCT04287075: Clinical Trial study, sponsored by Axogen Corporation.
NCT04287075 is a clinical trial that was terminated before completion, run by Axogen Corporation. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04287075 was terminated before completion, sponsored by Axogen Corporation.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Observational registry study assessing the subject's pain history and the impact of surgery for the treatment of chronic neuropathic pain by comparing post-operative outcomes (pain level, pain medication usage, quality of life outcomes, and nerve functional outcome) to pre-operative levels.
Primary Outcome
The Visual Analog Scale (VAS) for Pain is a patient reported outcomes scale whereby the patient indicates his/her current pain level by making a mark on a continuous horizontal 10-centimeter (100 millimeter) line. The distance from the 0 millimeter to the patient's mark corresponds to the amount of pain the subject is currently experiencing. VAS for Pain data are recorded as the number of millimeters from the left of the line to the patients mark across the range of 0-100 millimeters, with 0 mil
Interventions
- PROCEDURE Surgical Management of Neuroma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2024-01-24 |
Why NCT04287075 stopped before completion
NCT04287075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Surgical Management of Neuroma is the first listed.
NCT04287075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04287075 about?
NCT04287075 is a clinical study titled "Surgical Treatment of Chronic Neuropathic Pain". Observational registry study assessing the subject's pain history and the impact of surgery for the treatment of chronic neuropathic pain by comparing post-operative outcomes (pain level, pain medication usage, quality of life outcomes, and nerve functional outcome) to pre-operative levels.
What is the current status of trial NCT04287075?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2020-02-19. Estimated completion is 2024-01-24.
What interventions are being tested in trial NCT04287075?
The interventions under investigation include: Surgical Management of Neuroma (PROCEDURE).
Who is sponsoring clinical trial NCT04287075?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI